28 results
424B3
3f0niceyrd
10 Nov 21
Prospectus supplement
5:15pm
8-K
EX-99.1
anoo 9ozx834q
10 Nov 21
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
4:12pm
8-K
8a3nuf15
10 Nov 21
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
4:12pm
424B3
qswy3rwhfy1
11 Mar 21
Prospectus supplement
9:56pm
424B4
69uo0l9
8 Jan 21
Prospectus supplement with pricing info
9:38pm
8-K
EX-99.1
5phl7jepymewzh d625
5 Jan 21
Sven Guenther, Ph.D., our executive vice president, research and development; and Summary Compensation Table
9:10am
8-K
EX-10.1
22nqum6
24 Jun 20
Other Events
4:13pm